chr12-109139711-C-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001093.4(ACACB):c.306C>A(p.Asn102Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00034 in 1,613,958 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001093.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACACB | ENST00000338432.12 | c.306C>A | p.Asn102Lys | missense_variant | 2/53 | 1 | NM_001093.4 | ENSP00000341044.7 | ||
ACACB | ENST00000377848.7 | c.306C>A | p.Asn102Lys | missense_variant | 1/52 | 1 | ENSP00000367079.3 | |||
ACACB | ENST00000539864.1 | c.231C>A | p.Asn77Lys | missense_variant | 2/2 | 3 | ENSP00000443494.1 | |||
ACACB | ENST00000377854 | c.-3697C>A | 5_prime_UTR_variant | 1/47 | 5 | ENSP00000367085.6 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152152Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000183 AC: 46AN: 251346Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135824
GnomAD4 exome AF: 0.000351 AC: 513AN: 1461806Hom.: 0 Cov.: 30 AF XY: 0.000348 AC XY: 253AN XY: 727190
GnomAD4 genome AF: 0.000237 AC: 36AN: 152152Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74322
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.306C>A (p.N102K) alteration is located in exon 1 (coding exon 1) of the ACACB gene. This alteration results from a C to A substitution at nucleotide position 306, causing the asparagine (N) at amino acid position 102 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 14, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at